跳转至内容
Merck

G6295

Sigma-Aldrich

GW3965 盐酸盐

≥98% (HPLC), powder, liver X receptors agonist

别名:

3- [3- [N-(2-氯-3-三氟甲基苄基) - (2,2-二苯乙基)氨基]丙氧基]苯乙酸 盐酸盐

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C33H31F3ClNO3 · HCl
分子量:
618.51
MDL號碼:
分類程式碼代碼:
12352200
PubChem物質ID:
NACRES:
NA.77

product name

GW3965 盐酸盐, ≥98% (HPLC), powder

品質等級

化驗

≥98% (HPLC)

形狀

powder

儲存條件

desiccated

顏色

white

溶解度

DMSO: ≥20 mg/mL

起源

GlaxoSmithKline

SMILES 字串

Cl[H].OC(=O)Cc1cccc(OCCCN(CC(c2ccccc2)c3ccccc3)Cc4cccc(c4Cl)C(F)(F)F)c1

InChI

1S/C33H31ClF3NO3.ClH/c34-32-27(15-8-17-30(32)33(35,36)37)22-38(18-9-19-41-28-16-7-10-24(20-28)21-31(39)40)23-29(25-11-3-1-4-12-25)26-13-5-2-6-14-26;/h1-8,10-17,20,29H,9,18-19,21-23H2,(H,39,40);1H

InChI 密鑰

NMPUWJFHNOUNQU-UHFFFAOYSA-N

生化/生理作用

GW3965是hLXRα和hLXRβ上的肝X受体完全激动剂。 在 LXRα 的无细胞配体感应测定中,GW3965 具有 EC 50 = 125 nM和并且在在基于细胞的测定中作为hLXRα和hLXRβ的完全激动剂分布, EC 50 = 190 nM 和 30 nM 。在小鼠中具有口服活性。当针对一组核受体进行筛选时,它只与孕烷 X 受体 (PXR) 发生交叉反应。文献激动剂 T0901317 (Tularik) 在无细胞和基于细胞的测定分别有 EC 50 = 60 nM 和 85 nM。

特點和優勢

该化合物由GlaxoSmithKline开发。要浏览其他药物开发化合物和批准的药物/候选药物列表,单击此处
这种化合物是基因调控研究的特色产品。点击此处发现更多特色基因调控产品。在sigma.com/discover-bsm可了解更多关于生物活性小分子的其他研究领域。

象形圖

CorrosionExclamation mark

訊號詞

Danger

危險聲明

危險分類

Acute Tox. 4 Oral - Aquatic Chronic 4 - Eye Dam. 1

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 3

閃點(°F)

Not applicable

閃點(°C)

Not applicable

個人防護裝備

dust mask type N95 (US), Eyeshields, Gloves


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

Mawien Karaca et al.
STAR protocols, 4(3), 102500-102500 (2023-08-24)
Here, we present an in vitro test battery to analyze chemicals for their potential to induce liver triglyceride accumulation, a hallmark of liver steatosis. We describe steps for using HepG2 and HepaRG human hepatoma cells in conjunction with a combination of
Alzbeta Stefela et al.
Frontiers in pharmacology, 12, 713149-713149 (2021-09-07)
Bile acids (BAs) are key signaling steroidal molecules that regulate glucose, lipid, and energy homeostasis via interactions with the farnesoid X receptor (FXR) and G-protein bile acid receptor 1 (GPBAR1). Extensive medicinal chemistry modifications of the BA scaffold led to
Zhen Lu et al.
Cell metabolism, 34(9), 1342-1358 (2022-09-08)
Effector trogocytosis between malignant cells and tumor-specific cytotoxic T lymphocytes (CTLs) contributes to immune evasion through antigen loss on target cells and fratricide of antigen-experienced CTLs by other CTLs. The mechanisms regulating these events in tumors remain poorly understood. Here
Yang Wu et al.
Molecular cancer research : MCR, 21(6), 591-604 (2023-03-18)
Estrogen receptor alpha (ER/ESR1) mutations occur in 30% to 40% of endocrine resistant ER-positive (ER+) breast cancer. Forkhead box A1 (FOXA1) is a key pioneer factor mediating ER-chromatin interactions and endocrine response in ER+ breast cancer, but its role in
Pablo Ríos-Marco et al.
Experimental cell research, 340(1), 81-90 (2015-12-30)
Alkylphospholipid (APL) analogs are a new class of membrane-directed synthetic compounds with a variety of biological actions and clinical applications. In particular, these agents are promising candidates in cancer treatment. We have demonstrated that after prolonged treatment APLs alter intracellular

商品

We offer a variety of small molecule research tools, such as transcription factor modulators, inhibitors of chromatin modifying enzymes, and agonists/antagonists for target identification and validation in gene regulation research; a selection of these research tools is shown below.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门